Open AccessEffects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction.
Author(s) -
Domenico Bonaduce,
F. Marcianò,
Mario Petretta,
M L Migaux,
G Morgano,
Valter Bianchi,
Luigi Salemme,
Giuseppe Valva,
M Condorelli
Publication year - 1994
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.90.1.108
Subject(s) - medicine , captopril , heart rate variability , myocardial infarction , cardiology , placebo , heart rate , electrocardiography , anesthesia , blood pressure , alternative medicine , pathology
Heart period variability provides useful prognostic information on autonomic cardiac control, and a strong association has been demonstrated after myocardial infarction (MI) between cardiac mortality, sudden death, and reduced total power, ultralow-frequency (ULF) power, and very-low-frequency (VLF) power. Converting enzyme inhibitors are widely used in MI patients, but their influence on heart period variability remains to be defined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom